{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:45:09Z","timestamp":1782380709185,"version":"3.54.5"},"reference-count":69,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:p>Excessive alcohol consumption represents an important burden for health systems worldwide and is a major cause of liver- and cancer-related deaths. Alcohol consumption is mostly assessed by self-report that often underestimates the amount of drinking. While alcohol use disorders identification test - version C is the most widely used test for alcohol use screening, in patients with liver disease the use of alcohol biomarker could help an objective assessment. The amount of alcohol that leads to significant liver disease depends on gender, genetic background, and coexistence of comorbidities (i.e., metabolic syndrome factors). All patients with alcohol-associated liver disease are recommended to follow complete abstinence and they should be treated within multidisciplinary teams. Abstinence slows down and even reverses the progression of liver fibrosis and can help recompensate patients with complicated cirrhosis. Whether there is a safe amount of alcohol in the general population is a matter of intense debate. Large epidemiological studies showed that the safe amount of alcohol to avoid overall health-related risks is lower than expected even in the general population. Even one drink per day can increase cancer-related death. In patients with any kind of chronic liver disease, especially in those with metabolic-associated steatotic liver disease, no alcohol intake is recommended. This review article discusses the current evidence supporting the deleterious effects of small-to-moderate amounts of alcohol in the general population and in patients with underlying chronic liver disease.<\/jats:p>","DOI":"10.1055\/s-0044-1785228","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T22:54:17Z","timestamp":1712271257000},"page":"069-078","source":"Crossref","is-referenced-by-count":11,"title":["Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?"],"prefix":"10.1055","volume":"44","author":[{"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[{"name":"UCM Digestive Diseases and CIBERehd, Institute of Biomedicine of Seville (HUVR\/CSIC\/US), Virgen del Roc\u00edo University Hospital, University of Seville, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Division of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western University and London Health Sciences Centre, London, Ontario, Canada"},{"name":"Department of Epidemiology and Biostatistics, Schulich School of Medicine, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia P.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Division of Clinical Gastroenterology and Hepatology, Department of Gastroenterology, Faculdade de Medicina, Universidade de S\u00e3o Paulo, Hospital das Cl\u00ednicas HCFMUSP, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Centro de Envejecimiento y Regeneraci\u00f3n, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cortez-Pinto","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universitaria de Gastrenterologia, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Bataller","sequence":"additional","affiliation":[{"name":"Liver Unit, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"D Q Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2188\/jea.JE20220175","article-title":"Cancer risk according to alcohol consumption trajectories: a population-based cohort study on 2.8 million Korean men","volume":"33","author":"T T Bui","year":"2022","journal-title":"J Epidemiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/S0140-6736(18)32744-2","article-title":"Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study","volume":"393","author":"J Manthey","year":"2019","journal-title":"Lancet"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1542\/peds.2006-1517","article-title":"Binge drinking and associated health risk behaviors among high school students","volume":"119","author":"J W Miller","year":"2007","journal-title":"Pediatrics"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/gut.2007.145573","article-title":"Effect of binge drinking on the liver: an alarming public health issue?","volume":"58","author":"P Mathurin","year":"2009","journal-title":"Gut"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/S2468-2667(18)30230-5","article-title":"Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study","volume":"4","author":"R F Simpson","year":"2019","journal-title":"Lancet Public Health"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.18632\/aging.204467","article-title":"Alcohol consumption and epigenetic age acceleration in young adults","volume":"15","author":"D R Nannini","year":"2023","journal-title":"Aging (Albany NY)"},{"issue":"08","key":"ref9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cgh.2018.11.033","article-title":"Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease","volume":"17","author":"Z M Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"c1240","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies","volume":"340","author":"C L Hart","year":"2010","journal-title":"BMJ"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jhepr.2019.07.009","article-title":"Public health policies and alcohol-related liver disease","volume":"1","author":"M Ventura-Cots","year":"2019","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1186\/s12889-019-7987-3","article-title":"Inaccuracies in survey reporting of alcohol consumption","volume":"19","author":"C Gilligan","year":"2019","journal-title":"BMC Public Health"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamainternmed.2019.6116","article-title":"Underappreciated bias created by measurement error in risk factor assessment-a case study of no safe level of alcohol consumption","volume":"180","author":"M C Vance","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/eurpub\/ckt016","article-title":"How is alcohol consumption affected if we account for under-reporting? A hypothetical scenario","volume":"23","author":"S Boniface","year":"2013","journal-title":"Eur J Public Health"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.15288\/jsad.2022.83.134","article-title":"Improving estimates of alcohol-attributable deaths in the United States: impact of adjusting for the underreporting of alcohol consumption","volume":"83","author":"M B Esser","year":"2022","journal-title":"J Stud Alcohol Drugs"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2009.02.013","article-title":"AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey","volume":"103","author":"M Aalto","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1530-0277.2006.00295.x","article-title":"The alcohol use disorders identification test: an update of research findings","volume":"31","author":"D F Reinert","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"M E Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2022.04.040","article-title":"Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease","volume":"77","author":"K Staufer","year":"2022","journal-title":"J Hepatol"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.08.030","article-title":"Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease","volume":"78","author":"F \u00c5berg","year":"2023","journal-title":"J Hepatol"},{"issue":"09","key":"ref21","first-page":"587","article-title":"[Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]","volume":"36","author":"R Gallego-Dur\u00e1n","year":"2013","journal-title":"Gastroenterol Hepatol"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cld.197","article-title":"Alcohol consumption as a cofactor for other liver diseases","volume":"2","author":"J Altamirano","year":"2013","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"33","key":"ref23","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.12998\/wjcc.v9.i33.10052","article-title":"Effects of alcohol consumption on viral hepatitis B and C","volume":"9","author":"H Q Xu","year":"2021","journal-title":"World J Clin Cases"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.aohep.2020.09.006","article-title":"Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease","volume":"19","author":"J P Arab","year":"2020","journal-title":"Ann Hepatol"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver (EASL)","year":"2016","journal-title":"J Hepatol"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"N Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"19","key":"ref27","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1001\/jama.287.19.2559","article-title":"Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial","volume":"287","author":"M J Davies","year":"2002","journal-title":"JAMA"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2337\/diacare.27.1.184","article-title":"Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity","volume":"27","author":"A Sierksma","year":"2004","journal-title":"Diabetes Care"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jnutbio.2010.07.004","article-title":"Effects of resveratrol and other wine polyphenols on vascular function: an update","volume":"22","author":"P Gresele","year":"2011","journal-title":"J Nutr Biochem"},{"issue":"09","key":"ref30","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/ajg.2009.361","article-title":"Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population","volume":"104","author":"T Gunji","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00365521.2016.1239759","article-title":"Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease","volume":"52","author":"H Hagstr\u00f6m","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41395-018-0133-5","article-title":"Type and pattern of alcohol consumption is associated with liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"113","author":"T Mitchell","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2014.11.025","article-title":"Roles of alcohol consumption in fatty liver: a longitudinal study","volume":"62","author":"A Moriya","year":"2015","journal-title":"J Hepatol"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2012.03.024","article-title":"Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"57","author":"W Dunn","year":"2012","journal-title":"J Hepatol"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1465-3362.2009.00153.x","article-title":"Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis","volume":"29","author":"J Rehm","year":"2010","journal-title":"Drug Alcohol Rev"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.14309\/ajg.0000000000000340","article-title":"Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis","volume":"114","author":"M Roerecke","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/00365520802555991","article-title":"Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease","volume":"44","author":"M Ekstedt","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"09","key":"ref38","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.cgh.2018.01.026","article-title":"Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis","volume":"16","author":"V Ajmera","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/acer.14271","article-title":"Interaction between alcohol use and metabolic risk factors for liver disease: a critical review of epidemiological studies","volume":"44","author":"F \u00c5berg","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.29055","article-title":"Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review","volume":"65","author":"V H Ajmera","year":"2017","journal-title":"Hepatology"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease","volume":"66","author":"C Lackner","year":"2017","journal-title":"J Hepatol"},{"issue":"26","key":"ref42","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"R Bataller","year":"2022","journal-title":"N Engl J Med"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0016-5085(97)70142-2","article-title":"Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis","volume":"112","author":"A Luca","year":"1997","journal-title":"Gastroenterology"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/liv.12559","article-title":"Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure","volume":"35","author":"G Mehta","year":"2015","journal-title":"Liver Int"},{"issue":"03","key":"ref45","first-page":"282","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","author":"M R Thursz","year":"2015","journal-title":"N Engl J Med"},{"issue":"09","key":"ref46","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/00365520410006350","article-title":"Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit","volume":"39","author":"H Bell","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0676.2003.01804.x","article-title":"Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence","volume":"23","author":"F Pessione","year":"2003","journal-title":"Liver Int"},{"issue":"24","key":"ref48","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJM199712113372401","article-title":"Alcohol consumption and mortality among middle-aged and elderly U.S. adults","volume":"337","author":"M J Thun","year":"1997","journal-title":"N Engl J Med"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/ijc.27508","article-title":"Influences of tobacco and alcohol use on hepatocellular carcinoma survival","volume":"131","author":"W L Shih","year":"2012","journal-title":"Int J Cancer"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"E Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"issue":"S 01","key":"ref51","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.clinre.2015.06.005","article-title":"Management of alcohol recurrence before and after liver transplantation","volume":"39","author":"C A Marroni","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"06","key":"ref52","doi-asserted-by":"crossref","first-page":"843","DOI":"10.5009\/gnl220545","article-title":"Nonalcoholic fatty liver disease as a systemic disease and the need for multidisciplinary care","volume":"17","author":"M Yoneda","year":"2023","journal-title":"Gut Liver"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL Clinical Practice Guidelines: management of alcohol-related liver disease","volume":"69","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu","year":"2018","journal-title":"J Hepatol"},{"issue":"06","key":"ref54","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/liv.15221","article-title":"Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines","volume":"42","author":"A Louvet","year":"2022","journal-title":"Liver Int"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.aohep.2019.04.005","article-title":"Alcohol-related liver disease: clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)","volume":"18","author":"J P Arab","year":"2019","journal-title":"Ann Hepatol"},{"issue":"07","key":"ref57","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/add.13341","article-title":"Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries","volume":"111","author":"A Kalinowski","year":"2016","journal-title":"Addiction"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/joim.12390","article-title":"Alcohol and cardiovascular diseases: where do we stand today?","volume":"278","author":"A L Klatsky","year":"2015","journal-title":"J Intern Med"},{"issue":"02","key":"ref59","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.atherosclerosis.2014.03.001","article-title":"Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease","volume":"234","author":"D H Sinn","year":"2014","journal-title":"Atherosclerosis"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/j.gastro.2017.08.012","article-title":"Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease","volume":"153","author":"L B VanWagner","year":"2017","journal-title":"Gastroenterology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599\u2008912 current drinkers in 83 prospective studies","volume":"391","author":"A M Wood","year":"2018","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"GBD 2016 Alcohol Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/bjc.2014.579","article-title":"Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis","volume":"112","author":"V Bagnardi","year":"2015","journal-title":"Br J Cancer"},{"issue":"10","key":"ref64","first-page":"657","article-title":"Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH","volume":"42","author":"R Bataller","year":"2019","journal-title":"Gastroenterol Hepatol"},{"issue":"06","key":"ref65","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/acer.12045","article-title":"The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots","volume":"37","author":"L N Bakhireva","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"06","key":"ref66","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jat\/bkz035","article-title":"Fully automated determination of phosphatidylethanol 16:0\/18:1 and 16:0\/18:2 in dried blood spots","volume":"43","author":"M Luginb\u00fchl","year":"2019","journal-title":"J Anal Toxicol"},{"issue":"11","key":"ref67","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/acer.12883","article-title":"Phosphatidylethanol is superior to carbohydrate-deficient transferrin and \u03b3-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level","volume":"39","author":"L Walther","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41596-020-00416-x","article-title":"Quantitative determination of phosphatidylethanol in dried blood spots for monitoring alcohol abstinence","volume":"16","author":"M Luginb\u00fchl","year":"2021","journal-title":"Nat Protoc"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e936293","DOI":"10.12659\/AOT.936293","article-title":"Phosphatidylethanol (PEth) for monitoring sobriety in liver transplant candidates: preliminary results of differences between alcohol-related and non-alcohol-related cirrhosis candidates","volume":"27","author":"J P Gundlach","year":"2022","journal-title":"Ann Transplant"},{"issue":"04","key":"ref70","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2006.08.020","article-title":"Utility of a new model to diagnose an alcohol basis for steatohepatitis","volume":"131","author":"W Dunn","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1785228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:17:41Z","timestamp":1730823461000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1785228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":69,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,4,16]]},"published-print":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1785228","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}